Expression of the transforming growth factor β isoforms in inflammatory cells of nasal polyps

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 12, 1998, Pages 1361-1366

  Coste, André ^a,b   Lefaucheur, Jean Pascal ^a   Wang, Qiu Pin ^a   Lesprit, Emmanuelle ^c   Poron, Françoise ^b   Peynegre, Roger ^a   Escudier, Estelle ^b,d  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; ETHMOIDECTOMY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MACROPHAGE; NOSE MUCOSA; NOSE POLYP; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM;

EID: 0031673617     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.12.1361     Document Type: Article

References (27)

1. Kakoi H, Hiraide F. A histological study of formation and growth of nasal polyps. Acta Otolaryngol (Stockh). 1987;103:137-144.
2. Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990;141:765-788.
3. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol. 1990; 6:597-641.
4. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol. 1992;5:1017-1021.
5. Mustoe TA, Pierce GF, Thomason A, et al. Transforming growth factor beta induces accelerated healing of incisional wounds in rats. Science. 1987;237:1333-1336.
6. Border RW, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
7. Yamauchi K, Martinet Y, Basset TP, et al. High levels of transforming growth factor-β are present in the epithelial lining fluid of the normal human lower respiratory tract. Am Rev Respir Dis. 1988;137:1360-1363.
8. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated macrophages. Proc Natl Acad Sci U S A. 1987;84:6020-6024.
9. 2 by primary cultures of bronchial epithelial cell. J Clin Invest. 1992;90:1379-1385.
10. 1). J Clin Invest. 1992;89:1662-1668.
11. Roberts AB, Lamb LC, Newton DL, et al. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A. 1980;77:3494-3498.
12. 1 down-regulates the platelet-derived growth factor a-receptor subtype on human lung fibroblasts in vitro. Am J Respir Cell Mol Biol. 1995;13:496-505.
13. Ke Y, Gerwin BI, Ruskie SE, et al. Cell density governs the ability of human bronchial epithelial cells to recognize serum and transforming growth factor beta-1 as squamous differentiation-inducing agents. Am J Pathol. 1990;137:833-843.
14. Härkönen E, Virtanen I, Linnala A, et al. Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am J Respir Cell Mol Biol. 1995;13:109-115.
15. 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol. 1996;14:131-138.
16. Whal SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:1037-1050.
17. Ranges GE, Figari IS, Espevik T, et al. Inhibition of cytokine T-cell development by transforming growth factor-β and reversal by tumor necrosis factor-α. J Exp Med. 1987;166:991-998.
18. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science. 1988;242:97-99.
19. Nelson BJ, Ralph P, Gree SJ, et al. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J Immunol. 1991;146:1849-1857.
20. Postlethwaite AE, Keski-Oja J, Moses HL, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med. 1987;165:251-256.
21. Larsen P, Tos M, Kuijpers W, et al. The early stages of polyp formation. Laryngoscope. 1992;102:670-677.
22. Norlander T, Westrin KM, Fukami M, et al. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope. 1996; 106:196-203.
23. Coste A, Bateau JG, Roudot-Thoraval F, et al. Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg. 1996;122: 432-436.
24. Coste A, Wang QP, Roudot-Thoraval F, et al. Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth-factor. Laryngoscope. 1996;106:578-583.
25. Rundhaug JE, Nettesheim P. Growth regulation of primary rat tracheal epithelial cell cultures by endogenous transforming growth factor-βs. J Cell Physiol. 1992; 155:483-493.
26. Volberg TM, Gearge MD, Nervi IC, et al. Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells. Am J Respir Cell Mol Biol. 1992;7:10-18.
27. Twardzik DR, Ranchalis JE, McPherson JM, et al. Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinat forms of transforming growth factor-β. J Natl Cancer Inst. 1988;81:1182-1185.